125: A Prioritization Framework for the Analysis of Near Misses in Radiation Oncology

2021 ◽  
Vol 163 ◽  
pp. S54
Author(s):  
Brian Liszewski
2021 ◽  
Vol 161 ◽  
pp. S1434-S1435
Author(s):  
N. Jornet ◽  
J. Perez Alija ◽  
S. Bermejo ◽  
N. Ventosa ◽  
A. Pedro ◽  
...  

2021 ◽  
Vol 47 (1) ◽  
pp. 15-22
Author(s):  
Olivia S. Jung ◽  
Palak Kundu ◽  
Amy C. Edmondson ◽  
John Hegde ◽  
Nzhde Agazaryan ◽  
...  

2020 ◽  
Vol 10 (5) ◽  
pp. e312-e321
Author(s):  
Gregory D. Judy ◽  
Daniel P. Lindsay ◽  
Deen Gu ◽  
Brandon T. Mullins ◽  
Prithima R. Mosaly ◽  
...  

2010 ◽  
Vol 49 (S 01) ◽  
pp. S11-S15
Author(s):  
C. Schütze ◽  
M. Krause ◽  
A. Yaromina ◽  
D. Zips ◽  
M. Baumann

SummaryRadiobiological and cell biological knowledge is increasingly used to further improve local tumour control or to reduce normal tissue damage after radiotherapy. Important research areas are evolving which need to be addressed jointly by nuclear medicine and radiation oncology. For this differences of the biological distribution of diagnostic and therapeutic nuclides compared with the more homogenous dose-distribution of external beam radiotherapy have to be taken into consideration. Examples for interdisciplinary biology-based cancer research in radiation oncology and nuclear medicine include bioimaging of radiobiological parameters characterizing radioresistance, bioimage-guided adaptive radiotherapy, and the combination of radiotherapy with molecular targeted drugs.


Sign in / Sign up

Export Citation Format

Share Document